BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdalla AE, Mahjoob MO, Abosalif KOA, Ejaz H, Alameen AAM, Elsaman T. Human cytomegalovirus-encoded MicroRNAs: A master regulator of latent infection. Infection, Genetics and Evolution 2020;78:104119. [DOI: 10.1016/j.meegid.2019.104119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Adamson CS, Nevels MM. Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function. Viruses 2020;12:E110. [PMID: 31963209 DOI: 10.3390/v12010110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
2 Namasivayam V, Palaniappan S, Vanangamudi M. Repurposing drugs targeting epidemic viruses. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fernández-Moreno R, Torre-Cisneros J, Cantisán S. Human cytomegalovirus (HCMV)-encoded microRNAs: potential biomarkers and clinical applications. RNA Biol 2021;:1-9. [PMID: 34039247 DOI: 10.1080/15476286.2021.1930757] [Reference Citation Analysis]
4 Wower IK, Brandebourg TD, Wower J. New Insights on the Mobility of Viral and Host Non-Coding RNAs Reveal Extracellular Vesicles as Intriguing Candidate Antiviral Targets. Pathogens 2020;9:E876. [PMID: 33114356 DOI: 10.3390/pathogens9110876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yu M, Jin Y, Zhang S, Xu J, Zhang J. microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells. Vaccines 2022;10:144. [DOI: 10.3390/vaccines10020144] [Reference Citation Analysis]